Eric Thomas Schmidt, Chief Financial Officer at Allogene Therapeutics, Inc. (ALLO), sold 5,450 shares at $19.70 ($108K) on 2020-03-16, disclosed to the SEC on 2020-03-18.
Open-market sale of $108k ALLO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.70 | 5,150 | $101K | 94.4% |
| 2 | $20.25 | 300 | $6K | 5.6% |
| Total | $19.73 avg | 5,450 | $108K | 100% |
| Filing → |
| ALLO | SELL | 2021-01-19 | $1.9M | — | Filing → |
| ALLO | SELL | 2020-11-18 | $644K | — | Filing → |
| ALLO | SELL | 2020-10-16 | $1.2M | — | Filing → |